- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Paying, Not Penalizing, Patients to Stay Healthy
A study published in the New England Journals of Medicine evaluated the ability of financial incentives in promoting smoking cessation.
A collaborative study between academic health policy centers and CVS Caremark, published in the New England Journal of Medicine, evaluated whether financial incentives among CVS Caremark employees and their families and friends would promote smoking cessation. The randomized trial assigned people to either individual incentive programs or group incentive programs in the form of direct rewards or refundable deposits; additionally, trial partcipants had access to information resources and were provided smoking cessation aids.
The trial found that reward-based programs were more successful in sustaining abstinence from smoking over the 6-month monitoring period, than were deposit-based programs. Also, group-based programs seemed to work better than the individual approach.
Read the paper in the current issue of NEJM: http://bit.ly/1FF2U1H
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More
